Kimberly Kay Leslie

6PUBLICATIONS
16CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied geophysicsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 23, 2025
Auranofin Synergizes with Cisplatin in Reducing Tumor Burden of NOTCH-Dependent Ovarian Cancer.

Robert J Lake, Parisa Nikeghbal, Irina V Lagutina

|Feb 26, 2025
Enhancing Progestin Therapy with a Glucagon-Like Peptide 1 Agonist for the Conservative Management of Endometrial Cancer.

Andrea R Hagemann, Ian S Hagemann, David G Mutch

|Sep 16, 2022
Reply to E. Guerra et al.

Kimberly Kay Leslie, Kristina Thiel

|Jun 06, 2022
TP53 Sequencing and p53 Immunohistochemistry Predict Outcomes When Bevacizumab Is Added to Frontline Chemotherapy in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study.

Kristina W Thiel, Eric J Devor, Virginia L Filiaci

|Jan 18, 2022
Blocking autophagy overcomes resistance to dual histone deacetylase and proteasome inhibition in gynecologic cancer.

Jianling Bi, Yuping Zhang, Paige K Malmrose

|Jan 17, 2019
Combination of Proteasome and Histone Deacetylase Inhibitors Overcomes the Impact of Gain-of-Function p53 Mutations.

Xiangbing Meng, Shujie Yang, Yujun Li

Pageof 1

Frequent Collaborators

3 joint publications

Eric J Devor

3 joint publications

Kristina W Thiel

2 joint publications

David Mutch

1 joint publications

Xiangbing Meng